Novartis’s cancer therapy wins UK backing after initial lymphoma snub

ZURICH (Reuters) – Novartis’s Kymriah cell therapy won the blessing of health authorities in England for adult lymphoma patients, the Swiss drugmaker said on Friday, reversing last year’s rejection.

FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

The list price is 282,000 pounds ($369,000) per patient, given as a single intravenous infusion, but Novartis agreed to offer the therapy for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) at a confidential discounted price, the National Institute for Health and Care Excellence (NICE) said.

Plunging Temperatures a Threat to People With Alzheimer’s

News Picture: Plunging Temperatures a Threat to People With Alzheimer's

Latest Alzheimer’s News

WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The polar vortex that has enveloped much of the United States this week poses a special danger to people with Alzheimer’s disease and other types of dementia.

“This type of weather can be hazardous for everyone, but even more so for individuals living with Alzheimer’s disease, who may have difficulty noticing temperature and weather changes or knowing who to call for help,” said Charles Fuschillo Jr., CEO and president of the Alzheimer’s Foundation of America.

Go red to support women fighting heart disease

Every minute, heart disease takes the life of a woman in the United States, even though nearly 80% of cardiac events can be prevented. Heart disease doesn’t affect every woman in the same way, but there are signs to look for and ways to help prevent it.

Medicare covers cardiovascular disease screenings every 5 years for people with Part B. Quitting smoking also helps lower your risk of heart disease, and Medicare covers smoking and tobacco use cessation counseling for people with Part B.

National Wear Red Day is February 1st. Support the women in your life and #WearRedandGive.

Visit the Source Site

Low-calorie diet prevents asthma symptoms in mice, study finds

Jan 31 2019

Experimenting with mice, Johns Hopkins Medicine researchers report that a low-calorie diet prevented asthma symptoms regardless of the diet’s fat and sugar content. The researchers also say they found that obesity resulting from a high-calorie diet led to asthma symptoms in the animals by causing lung inflammation, and a drug that blocks inflammation eased those symptoms.

Credit: iStock